Femodene ED

Country: New Zealand

Language: English

Source: Medsafe (Medicines Safety Authority)

Active ingredient:

Ethinylestradiol 0.03mg; Gestodene 0.075mg

Available from:

Bayer New Zealand Limited

INN (International Name):

Ethinylestradiol 0.03 mg

Pharmaceutical form:

Tablet

Composition:

Active: Ethinylestradiol 0.03mg Gestodene 0.075mg Excipient: Calcium carbonate Glycol montanate Lactose monohydrate Macrogol 6000 Magnesium stearate Maize starch Povidone   Purified talc Sodium calcium edetate Sucrose Lactose monohydrate

Units in package:

Blister pack, 2x (21 + 7), 56 tablets

Class:

Prescription

Prescription type:

Prescription

Manufactured by:

Bayer AG

Product summary:

Package - Contents - Shelf Life: Blister pack, 2x (21 + 7) - 56 tablets - 60 months from date of manufacture stored at or below 25°C - Calendar pack, 1x (21 + 7) - 28 tablets - 60 months from date of manufacture stored at or below 25°C - Calendar pack, 3 x (21 + 7) - 84 tablets - 60 months from date of manufacture stored at or below 25°C

Authorization date:

1987-12-21